Literature DB >> 8425627

Tumor necrosis factor-alpha alters steroidogenesis and stimulates proliferation of human ovarian granulosal cells in vitro.

Z Yan1, V Hunter, J Weed, S Hutchison, R Lyles, P Terranova.   

Abstract

OBJECTIVE: To determine if tumor necrosis factor alpha (TNF-alpha) altered human granulosa-luteal cell proliferation and steroidogenesis.
DESIGN: Aspirates of follicles from women undergoing in vitro fertilization were subjected to Percoll gradients to collect an enriched population of granulosa-luteal cells. The granulosa-luteal cells were subjected to culture for a period of 10 or 20 days in the presence or absence of various doses of human recombinant TNF-alpha (0.1 to 10.0 ng/mL). PATIENTS: Granulosa-luteal cells from nine patients were evaluated for their response to TNF-alpha in vitro. Patients with three follicles > 16 mm and a serum estradiol (E2) concentration of > 1,836 pmol/L were selected for study.
RESULTS: Tumor necrosis factor-alpha increased granulosa-luteal cell number. By day 10 of culture, 10 ng TNF-alpha/mL doubled cell number and > 95% of the cells exhibited 3 beta-hydroxysteroid dehydrogenase. Tumor necrosis factor-alpha at 10 ng/mL increased progesterone (P) accumulation from day 4 through day 20 of culture. Tumor necrosis factor-alpha also increased E2 secretion but in a biphasic manner. During the first 14 days of culture, TNF-alpha increased E2, but thereafter E2 decreased to basal values by day 20. When steroidogenesis was expressed per 1,000 cells per days of culture, TNF-alpha did not increase P beyond controls but significantly increased E2 for the first 14 days of culture after which E2 per 1,000 cells declined.
CONCLUSIONS: The results indicate that TNF-alpha stimulates granulosal-luteal cell growth and E2 secretion in vitro, and thus TNF-alpha may promote cellular events associated with formation of the corpus luteum; i.e., granulosa-cell proliferation and steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425627     DOI: 10.1016/s0015-0282(16)55676-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Tumor necrosis factor alpha inhibition of follicle-stimulating hormone-induced granulosa cell estradiol secretion in the human does not involve reduction of cAMP secretion but inhibition at post-cAMP site(s).

Authors:  V Montgomery Rice; S D Limback; K F Roby; P F Terranova
Journal:  Endocrine       Date:  1999-02       Impact factor: 3.633

2.  Form of dietary selenium affects mRNA encoding cholesterol biosynthesis and immune response elements in the early luteal phase bovine corpus luteum.

Authors:  Benjamin R Crites; Sarah N Carr; James C Matthews; Phillip J Bridges
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

3.  Estrogens modulate the inhibitory effect of tumor necrosis factor-alpha on anterior pituitary cell proliferation and prolactin release.

Authors:  S Theas; D Pisera; B Duvilanski; A De Laurentiis; M Pampillo; M Lasaga; A Seilicovich
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.925

4.  CXCL12 May Drive Inflammatory Potential in the Ovine Corpus Luteum During Implantation.

Authors:  Stacia Z McIntosh; Kelsey E Quinn; Ryan L Ashley
Journal:  Reprod Sci       Date:  2021-11-09       Impact factor: 3.060

Review 5.  Multiple roles of TNF super family members in corpus luteum function.

Authors:  Kiyoshi Okuda; Ryosuke Sakumoto
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

6.  Tumor necrosis factor-alpha (TNF-alpha) inhibits steroidogenesis of bovine ovarian granulosa and thecal cells in vitro. Involvement of TNF-alpha receptors.

Authors:  L J Spicer
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.925

7.  Effect of lipopolysaccharide on tumor necrosis factor and prolactin release from rat anterior pituitary cells.

Authors:  M S Theas; A De Laurentis; M Lasaga; D Pisera; B H Duvilanski; A Seilcovich
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.